Highlights from DYAI's recent company updates on protein expression technology and partnerships Dyadic Applied ...

SmallCaps Daily Sits Down with Joe Hazelton to Discuss Dyadic's Product Strategy, Strategic Partnerships, and Long-Term ...

Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals. What Happened: On Thursday prior ...

Emergent BioSolutions (NYSE:EBS) layoffs are in the news as the life sciences company prepares to cut jobs and close down certain facilities. According to a release from Emergent BioSolutions, these ...

View Emergent BioSolutions Inc. EBS stock quote prices, financial information, real-time forecasts, and company news from CNN.

How does the mpox outbreak impact Emergent BioSolutions? The only approved vaccine for preventing mpox is made by Bavarian Nordic. However, the U.S. Centers for Disease Control and Prevention (CDC) ...

Emergent enters into a forbearance agreement, securing flexible credit terms on its existing credit agreement. Emergent BioSolutions sees first-quarter revenue between $200 million and $250 million, ...

Emergent BioSolutions' top line has been nosediving in recent quarters. The company's operations are also unprofitable, and the business is burning through cash. Its flagship product, Narcan, will ...

A new report reveals that biosolutions could generate EUR 133 billion in economic gains and create over 600,000 jobs across all of Europe by 2035. But without urgent policy leadership and better ...

Monday - Friday, 6:00 - 7:00 PM ET Emergent BioSolutions, a behind-the-scenes player in the U.S. coronavirus vaccine program, has built capacity to produce vaccines from AstraZeneca and Johnson & ...